Statins Linked to Higher Risk of Back Problems

Use of a common class of drugs used to lower cholesterol may increases one’s risk of developing back problems.

Researchers examined data on 14,000 adults more than 30 years old who were enrolled in TRICARE, the military’s health care program. Half had taken a statin drug an average of 3.7 years while the others had never taken one. Zocor (simvastatin) was the most commonly taken statin in the study.

Statin users had a higher likelihood of back disorders, such as spondylosis and intervertebral disc disorder, the researchers reported in JAMA Internal Medicine.

Researchers did caution that because the study subjects were TRICARE enrollees, they are not sure if the results would be applicable to those who lead a more sedentary lifestyle.

“Our results provide additional motivation to further investigate the overall influence of statin therapy on musculoskeletal health, specifically if prescribed for primary prevention in physically active individuals,” the researchers concluded.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement